Recombinant human activated protein C in sepsis: inconsistent trial results, an unclear mechanism of action, and safety concerns resulted in labeling restrictions and the need for phase IV trials
- PMID: 12544982
- DOI: 10.1097/00003246-200301001-00013
Recombinant human activated protein C in sepsis: inconsistent trial results, an unclear mechanism of action, and safety concerns resulted in labeling restrictions and the need for phase IV trials
Comment in
-
Pro/Con debate of activated protein C in severe sepsis.Crit Care Med. 2003 Aug;31(8):2249. doi: 10.1097/01.CCM.0000087327.59341.18. Crit Care Med. 2003. PMID: 12973192 No abstract available.
-
Recombinant activated protein C.Crit Care Med. 2004 Jan;32(1):311-2. doi: 10.1097/01.CCM.0000104932.57061.AD. Crit Care Med. 2004. PMID: 14707611 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical